Medicare Enrolled
Dr. Edmond Lee, MD
Hematology & Oncology · Monterey Park, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Edmond Lee is a hematology & oncology specialist in Monterey Park, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 6,267 Medicare services across 753 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lee received a total of $5,135 from 33 pharmaceutical and/or device companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 31% volume in CA
$5,135 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,267
Medicare services
Top 31% in CA for hematology & oncology
753
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~330 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,360 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 952 | $0 | $1 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
411 | $98 | $125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
368 | $87 | $150 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
295 | $14 | $35 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
286 | $25 | $50 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
213 | $1 | $5 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
191 | $43 | $58 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
177 | $66 | $85 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
131 | $12 | $35 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
131 | $34 | $75 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
122 | $38 | $50 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
119 | $118 | $200 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
118 | $1 | $5 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
110 | $30 | $75 |
| Prolonged inpatient or observation care, each additional 15 minutes This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider. |
95 | $26 | $58 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
94 | $177 | $280 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
51 | $1 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $108 | $185 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.1% high complexity
69.0% medium
24.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,135
Total received (2018-2024)
Avg $734/year across 7 years
Top 43% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
151
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,175 (61.8%)
Other
Charitable contributions, space rental, and other categories
$1,615 (31.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$344 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$946
2023
$1,047
2022
$553
2021
$1,241
2020
$241
2019
$590
2018
$516
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$402
Novartis Pharmaceuticals Corporation
$112
PFIZER INC.
$71
ABBVIE INC.
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
Merck Sharp & Dohme LLC
$43
Aveo Pharmaceuticals, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$32
Gilead Sciences, Inc.
$29
Exelixis Inc.
$28
E.R. Squibb & Sons, L.L.C.
$23
Genentech USA, Inc.
$22
Coherus Biosciences Inc.
$21
Eisai Inc.
$20
Top 3 companies account for 61.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,828
Janssen Biotech, Inc.
$930
Amgen Inc.
$290
Dova Pharmaceuticals
$274
PFIZER INC.
$168
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Takeda Pharmaceuticals U.S.A., Inc.
$160
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
Incyte Corporation
$123
Genentech USA, Inc.
$89
Gilead Sciences, Inc.
$83
Lilly USA, LLC
$78
Merck Sharp & Dohme LLC
$72
SOBI, INC
$68
ABBVIE INC.
$63
TESARO, Inc.
$62
AstraZeneca Pharmaceuticals LP
$56
Puma Biotechnology, Inc.
$55
E.R. Squibb & Sons, L.L.C.
$43
Eisai Inc.
$40
Merck Sharp & Dohme Corporation
$40
Aveo Pharmaceuticals, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$32
Teva Pharmaceuticals USA, Inc.
$29
Exelixis Inc.
$28
Kite Pharma, Inc.
$27
ImmunoGen, Inc.
$26
Kyowa Kirin, Inc.
$23
Pharmacyclics LLC, An AbbVie Company
$22
Astellas Pharma US Inc
$21
Coherus Biosciences Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$19
Sobi, Inc
$17
Top 3 companies account for 59.4% of all-time payments
Associated products mentioned in payments ›
AFINITOR · ALIMTA · Alecensa · BAVENCIO · BENDEKA · CABOMETYX · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELAHERE · EMPLICITI · ERBITUX · EUCRISA · EXKIVITY · Elahere · FASLODEX · FOTIVDA · Fabhalta · GILOTRIF · ICLUSIG · IMBRUVICA · INLYTA · Imbruvica · JADENU · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LOQTORZI · LUMAKRAS · LUPRON DEPOT · Lenvima · NERLYNX · Nerlynx · Nplate · PLUVICTO · PROMACTA · REMICADE · RYBREVANT · Repatha · SANCUSO · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · Tecentriq · Trodelvy · VENCLEXTA · XTANDI · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
456
Per 100K population
4.6
County median income
$87,760
Nearest hospital
MONTEREY PARK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Lee performed 2,360 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $5,135 from 33 companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other hematology & oncology specialists in Monterey Park?
Dr. Lee's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Monterey Park
Browse hematology & oncology specialists in Monterey Park ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology